Study of the Combination of Anecortave Acetate and Triamcinolone Acetonide for the Treatment of Exudative Age-Related Macular Degeneration (AMD)
Alcon Research
Manhattan Eye, Ear & Throat Hospital

      The purpose of this study is to evaluate the safety of combining juxtasclerally administered
      anecortave acetate 15 mg with triamcinolone acetate 4 mg administered intravitreally
      following photodynamic therapy with verteporfin for the treatment of exudative age-related
      macular degeneration (AMD).
    
Drug